Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Rothe currently holds 82,698 shares of Greenwich LifeSciences, Inc. (GLSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Rothe has been a net buyer of GLSI stock. They have purchased $10.8K and sold $0 worth of shares.
Eric Rothe's most recent insider trade was on Dec 24, 2024, when they sold 41,349 shares at $0.00 per share.
Eric Rothe serves as Executive at Greenwich LifeSciences, Inc. (GLSI). They have executed 2 insider transactions totaling $10.8K over their tenure at the company.
Eric Rothe holds the position of Executive at Greenwich LifeSciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Eric Rothe has shown a buying trading pattern, with $10.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Eric Rothe was on Nov 20, 2020, when they purchased $10.8K worth of GLSI shares. This transaction involved 2,000 shares at $5.40 per share.
Eric Rothe currently owns 82,698 shares of Greenwich LifeSciences, Inc. (GLSI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Rothe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Rothe has 2 Form 4 filings on record as an insider at Greenwich LifeSciences, Inc..
Set alerts for Eric Rothe and 40,000+ other insiders.